stelo glucose biosensor fsa eligible: Your Questions Answered

The Stelo Glucose Biosensor launched in August 2024 as the first over-the-counter continuous glucose monitor in the U.S. For W2 employees and self-employed individuals using FSAs or HSAs, a key question is the Stelo glucose biosensor FSA eligible status. Dexcom markets it as a qualified medical expense, but understanding the specifics is vital to avoid reimbursement denials and maximize your tax-advantaged dollars. This guide breaks down eligibility, costs, and the steps to get your FSA or HSA to cover this $99 starter pack, helping you manage healthcare spending smartly.

26 questions covered across 4 categories

Eligibility and IRS Rules

Understanding the foundational tax rules and specific criteria that make the Stelo glucose biosensor a qualified medical expense for FSA and HSA

Costs, Budgeting, and FSA Limits

Planning your healthcare spending by understanding Stelo's pricing and how it interacts with annual FSA contribution limits and potential carryover

Purchase and Reimbursement Process

A step-by-step guide on how to successfully buy the Stelo biosensor and get your money back from your FSA or HSA, including documentation and common

Use Cases and Comparison to Other Options

Identifying who Stelo is designed for, how it compares to other glucose monitors and health accounts, and making informed choices for your specific

Summary

The Stelo Glucose Biosensor is FSA and HSA eligible as a qualified medical expense under IRS rules, offering a way for adults not using insulin to monitor glucose with tax-advantaged dollars. While Dexcom markets it as eligible, always confirm with your plan administrator and save a detailed receipt.

Pro Tips

  • Before buying Stelo, log into your FSA provider's portal and search their eligibility list for 'glucose monitor' or 'Dexcom'. Some systems have pre-loaded approved merchants and items.
  • If your FSA offers a debit card, buy Stelo directly with it from an approved pharmacy or Dexcom's website. This avoids the reimbursement paperwork entirely, but keep your receipt in case of an audit.
  • Consider timing your Stelo purchase. If you start a subscription in November, you might use current-year FSA funds for the starter pack and next year's funds for the ongoing monthly costs, smoothing out the expense.
  • For freelancers or those with an HSA, remember that HSA funds never expire. You can invest them. Paying for Stelo out-of-pocket now and reimbursing yourself later from the HSA lets your savings grow tax-free.
  • Always request an 'itemized receipt' at checkout, whether online or in-store. A simple credit card slip often lacks the product detail your FSA administrator requires for glucose biosensor claims.
  • If your doctor is supportive, ask them to write a Letter of Medical Necessity for 'continuous glucose monitoring for metabolic health management' even without an insulin requirement. This strengthens your reimbursement case.

Quick Answers

Is the Stelo Glucose Biosensor definitely FSA and HSA eligible?

Yes, Dexcom explicitly states the Stelo Glucose Biosensor is a qualified medical expense eligible for FSA and HSA funds. This is because it is an FDA-cleared device used for diagnosing and managing glucose levels, which falls under the IRS Publication 502 definition. However, the final approval for reimbursement always rests with your specific plan administrator. They may have their own documentation requirements, so it's best to check with them before purchasing.

What do I need to submit for FSA reimbursement for Stelo?

You typically need a detailed receipt that includes the date of purchase, the merchant name (Dexcom or the pharmacy), a clear item description like 'Stelo Glucose Sensor 2-pack', and the amount paid. Since Stelo is an OTC product, a prescription is not required for purchase. Some plan administrators might also ask for a Letter of Medical Necessity from your doctor, so confirming their specific rules upfront can prevent delays.

How much does the Stelo Glucose Biosensor cost, and how does it fit into my FSA budget?

The Stelo starter pack costs $99 for a 30-day supply containing two sensors. The subscription model is $89 per month, which totals about $1,068 annually. With the 2026 health FSA contribution limit set at $3,400 per employee, an annual Stelo subscription would use approximately 31% of your total limit. This makes it a significant but manageable expense within a well-planned FSA budget, especially for those tracking glucose without insulin.

Can I use my FSA for Stelo if I don't have diabetes?

Yes, you can. Stelo is approved for adults 18 and older who do not use insulin and do not have problematic hypoglycemia. This includes individuals with Type 2 diabetes, prediabetes, and non-diabetics who want to track their glucose responses to food and lifestyle. Since it is an FDA-cleared diagnostic device, its use for personal health monitoring qualifies as a medical expense under IRS rules, regardless of a formal diabetes diagnosis.

Will my health insurance cover the Stelo Glucose Biosensor?

No, Stelo is not covered by traditional health insurance plans. It is marketed and sold as an over-the-counter product directly to consumers. This makes FSA and HSA funds the primary tax-advantaged payment methods available for purchasing it. You cannot submit a claim to your medical insurance for reimbursement, so planning to use your FSA or HSA is the correct financial strategy.

What happens if my FSA plan administrator denies my Stelo reimbursement?

If your claim is denied, your first step should be to contact your plan administrator for a specific reason. Often, denials happen due to missing information on the receipt or a lack of prior confirmation that the expense is eligible. You can appeal the decision by providing Dexcom's marketing materials that state it's a qualified medical expense and referencing IRS Publication 502. Keeping clear records and pre-approving expenses when possible minimizes this risk.

How does the Stelo's eligibility compare to a traditional CGM like the Dexcom G7?

Both devices are eligible as qualified medical expenses. The key difference is access and insurance. The Dexcom G7 requires a prescription and is often covered by insurance for individuals with diabetes using insulin. Stelo is available over-the-counter without a prescription but is not covered by insurance. For FSA/HSA users, the reimbursement process is similar, but Stelo offers a lower barrier to entry for those not using insulin, though it comes with a full out-of-pocket cost.

Related Resources

More HSA Resources

Still have questions?

HSA Trackr makes the complex simple. Track expenses, maximize deductions, never miss a reimbursement.

See It In Action